This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Inhibition of TRPC6 reduces systemic inflammation, cardiac fibrosis, and dramatically improves survival in dystrophic cardiomyopathy. (31st December 2022)
Record Type:
Journal Article
Title:
Inhibition of TRPC6 reduces systemic inflammation, cardiac fibrosis, and dramatically improves survival in dystrophic cardiomyopathy. (31st December 2022)
Main Title:
Inhibition of TRPC6 reduces systemic inflammation, cardiac fibrosis, and dramatically improves survival in dystrophic cardiomyopathy